Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens

被引:6
作者
Chambers, Christina D. [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Pediat, Div Dysmorphol & Teratol, La Jolla, CA 92093 USA
关键词
cohort study; human teratogen; minor defect; physical examination; RETINOIC ACID EMBRYOPATHY; BIRTH OUTCOMES; CONGENITAL-MALFORMATIONS; EARLY-PREGNANCY; WOMEN; CHILDREN; RISK;
D O I
10.1111/j.1741-4520.2010.00310.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Most known human teratogens are associated with a unique or characteristic pattern of major and minor malformations and this pattern helps to establish the causal link between the teratogenic exposure and the outcome. Although traditional case-control and cohort study designs can help identify potential teratogens, there is an important role for small cohort studies that include a dysmorphological examination of exposed and unexposed infants for minor structural defects. In combination with other study design approaches, the small cohort study with a specialized physical examination fulfills a necessary function in screening for new potential teratogens and can help to better delineate the spectrum and magnitude of risk for known teratogens.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 17 条
[1]   Maternal Corticosteroid Use and Hypospadias [J].
Carmichael, Suzan L. ;
Ma, Chen ;
Werler, Martha M. ;
Olney, Richard S. ;
Shaw, Gary M. .
JOURNAL OF PEDIATRICS, 2009, 155 (01) :39-44
[2]   Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy [J].
Casper, RC ;
Fleisher, BE ;
Lee-Ancajas, JC ;
Gilles, A ;
Gaylor, E ;
DeBattista, A ;
Hoyme, HE .
JOURNAL OF PEDIATRICS, 2003, 142 (04) :402-408
[3]   Birth outcomes in pregnant women taking fluoxetine [J].
Chambers, CD ;
Johnson, KA ;
Dick, LM ;
Felix, RJ ;
Jones, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1010-1015
[4]  
Chambers CD, 1998, TERATOLOGY, V58, P251, DOI 10.1002/(SICI)1096-9926(199812)58:6<251::AID-TERA6>3.0.CO
[5]  
2-L
[6]   Postmarketing surveillance for human teratogenicity: A model approach [J].
Chambers, CD ;
Braddock, SR ;
Briggs, GG ;
Einarson, A ;
Johnson, YR ;
Miller, RK ;
Polifka, JE ;
Robinson, LK ;
Stepanuk, K ;
Jones, KL .
TERATOLOGY, 2001, 64 (05) :252-261
[7]   Birth Outcomes in Women Who Have Taken Leflunomide During Pregnancy [J].
Chambers, Christina D. ;
Johnson, Diana L. ;
Robinson, Luther K. ;
Braddock, Stephen R. ;
Xu, Ronghui ;
Lopez-Jimenez, Janina ;
Mirrasoul, Nicole ;
Salas, Elizabeth ;
Luo, Yunjun J. ;
Jin, Shelia ;
Jones, Kenneth Lyons .
ARTHRITIS AND RHEUMATISM, 2010, 62 (05) :1494-1503
[8]   Folic acid antagonists during pregnancy and the risk of birth defects [J].
Hernández-Díaz, S ;
Werler, MM ;
Walker, AM ;
Mitchell, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1608-1614
[9]   The AED (Antiepileptic drug) pregnancy registry - A 6-year experience [J].
Holmes, LB ;
Wyszynski, DF ;
Lieberman, E .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :673-678
[10]   Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations. [J].
Jentink, Janneke ;
Loane, Maria A. ;
Dolk, Helen ;
Barisic, Ingeborg ;
Garne, Ester ;
Morris, Joan K. ;
de Jong-van den Berg, Lolkje T. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (23) :2185-2193